Penserra Capital Management’s Twist Bioscience TWST Stock Holding History

Penserra Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,026	Closed	-$938K	–	1316
2024 Q2	$938K	Buy	+19,026	New	+$776K	0.01%	441
2022 Q2	–	Sell	-72	Closed	-$3K	–	1517
2022 Q1	$3K	Buy	+72	New	+$3.99K	﹤0.01%	1443
2021 Q4	–	Sell	-1,130	Closed	-$120K	–	1552
2021 Q3	$120K	Buy	1,130 +15	+1%	+$1.72K	﹤0.01%	730
2021 Q2	$148K	Buy	1,115 +15	+1%	+$1.74K	﹤0.01%	702
2021 Q1	$136K	Buy	1,100 +60	+6%	+$9.11K	﹤0.01%	648
2020 Q4	$146K	Buy	1,040 +658	+172%	+$73K	﹤0.01%	573
2020 Q3	$29K	Buy	+382	New	+$23.8K	﹤0.01%	697

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Penserra Capital Management's TWST Position: Q3 2024 in Review

Penserra Capital Management sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 19,026 shares — an estimated $938K sold.

Penserra Capital Management first reported a position in TWST in Q3 2020 and held it in 7 quarters. The position peaked at $938K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Penserra Capital Management reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Penserra Capital Management sold 19,026 Twist Bioscience shares in Q3 2024, an estimated $938K.
Penserra Capital Management first reported a position in Twist Bioscience in Q3 2020 and held it in 7 quarters.
Penserra Capital Management's Twist Bioscience position peaked at $938K in Q2 2024.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Penserra Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.